Meros Investment Management LP Purchases 8,540 Shares of Mesa Laboratories, Inc. $MLAB

Meros Investment Management LP increased its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 11.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 85,017 shares of the medical instruments supplier’s stock after purchasing an additional 8,540 shares during the period. Mesa Laboratories accounts for 2.6% of Meros Investment Management LP’s portfolio, making the stock its 15th largest holding. Meros Investment Management LP’s holdings in Mesa Laboratories were worth $6,674,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Mesa Laboratories by 4.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,068 shares of the medical instruments supplier’s stock valued at $364,000 after purchasing an additional 143 shares during the period. American Century Companies Inc. raised its position in shares of Mesa Laboratories by 1.5% during the 2nd quarter. American Century Companies Inc. now owns 13,431 shares of the medical instruments supplier’s stock valued at $1,265,000 after purchasing an additional 194 shares during the period. BNP Paribas Financial Markets raised its position in shares of Mesa Laboratories by 30.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,029 shares of the medical instruments supplier’s stock valued at $69,000 after purchasing an additional 243 shares during the period. Deutsche Bank AG raised its position in shares of Mesa Laboratories by 5.9% during the 4th quarter. Deutsche Bank AG now owns 4,440 shares of the medical instruments supplier’s stock valued at $349,000 after purchasing an additional 248 shares during the period. Finally, Northwestern Mutual Wealth Management Co. raised its position in shares of Mesa Laboratories by 5,366.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 322 shares during the period. 90.60% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday, June 3rd. Two equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and an average target price of $94.00.

Mesa Laboratories Trading Down 1.3%

MLAB stock opened at $104.08 on Tuesday. Mesa Laboratories, Inc. has a 1-year low of $55.45 and a 1-year high of $113.99. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.72 and a quick ratio of 1.29. The company has a market capitalization of $574.52 million, a price-to-earnings ratio of 86.73 and a beta of 0.94. The business has a 50 day simple moving average of $101.71 and a two-hundred day simple moving average of $90.40.

Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings results on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share for the quarter, missing the consensus estimate of $1.78 by ($0.25). Mesa Laboratories had a return on equity of 20.96% and a net margin of 2.69%.The business had revenue of $63.72 million during the quarter, compared to the consensus estimate of $65.21 million. During the same quarter in the previous year, the company earned ($1.31) earnings per share.

Mesa Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Friday, May 29th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, May 29th. Mesa Laboratories’s dividend payout ratio is 53.33%.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.